Squarepoint’s BioAtla BCAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-5,205
Closed -$90.3K 4493
2025
Q1
$90.3K Buy
5,205
+4,270
+457% +$91.3K ﹤0.01% 4244
2024
Q4
$27.6K Buy
+935
New +$78.5K ﹤0.01% 4913
2024
Q3
Sell
-1,412
Closed -$96.7K 4121
2024
Q2
$96.7K Buy
+1,412
New +$168K ﹤0.01% 3808
2024
Q1
Hold
0
4033
2023
Q2
Sell
-384
Closed -$51.4K 3566
2023
Q1
$51.4K Buy
384
+85
+28% +$15.3K ﹤0.01% 3053
2022
Q4
$123K Buy
+299
New +$124K ﹤0.01% 2930
2022
Q3
Sell
-698
Closed -$99K 3000
2022
Q2
$99K Sell
698
-1,404
-67% -$223K ﹤0.01% 2621
2022
Q1
$525K Buy
2,102
+1,765
+524% +$738K ﹤0.01% 1975
2021
Q4
$331K Buy
+337
New +$431K ﹤0.01% 2392
2021
Q3
Sell
-158
Closed -$336K 2914
2021
Q2
$336K Buy
+158
New +$357K ﹤0.01% 2444

Other funds holding BCAB